<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>TRAF6-pathway</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 900px;
            margin: 0 auto;
            padding: 20px;
            background: #f5f5f5;
        }
        .content {
            background: white;
            padding: 30px;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        h1, h2, h3, h4, h5, h6 {
            color: #2c3e50;
            margin-top: 24px;
            margin-bottom: 16px;
        }
        h1 { border-bottom: 2px solid #3498db; padding-bottom: 10px; }
        h2 { border-bottom: 1px solid #ecf0f1; padding-bottom: 8px; }
        code {
            background: #f4f4f4;
            padding: 2px 6px;
            border-radius: 3px;
            font-family: 'Courier New', monospace;
        }
        pre {
            background: #2c3e50;
            color: #ecf0f1;
            padding: 15px;
            border-radius: 5px;
            overflow-x: auto;
        }
        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }
        blockquote {
            border-left: 4px solid #3498db;
            margin-left: 0;
            padding-left: 20px;
            color: #555;
        }
        table {
            border-collapse: collapse;
            width: 100%;
            margin: 20px 0;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 12px;
            text-align: left;
        }
        th {
            background: #3498db;
            color: white;
        }
        tr:nth-child(even) {
            background: #f9f9f9;
        }
        .mermaid {
            text-align: center;
            margin: 30px 0;
            background: white;
            padding: 20px;
            border-radius: 8px;
            border: 1px solid #e0e0e0;
        }
        .mermaid svg {
            max-width: 100%;
            height: auto;
        }
        a {
            color: #3498db;
            text-decoration: none;
        }
        a:hover {
            text-decoration: underline;
        }
        .toc {
            background: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 5px;
            padding: 15px;
            margin-bottom: 20px;
        }
        .toc ul {
            list-style-type: none;
            padding-left: 20px;
        }
        .toc > ul {
            padding-left: 0;
        }
    </style>
    
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        // Initialize mermaid with custom settings
        mermaid.initialize({ 
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="content">
        <h1 id="pathway-summary-for-traf6">Pathway Summary for TRAF6</h1>
<h2 id="overview">Overview</h2>
<p>TRAF6 (TNF Receptor-Associated Factor 6) is a critical E3 ubiquitin ligase and signal transduction adaptor that synthesizes K63-linked polyubiquitin chains for non-degradative signaling. It serves as a central hub connecting multiple immune signaling pathways including Toll-like receptors (TLRs), interleukin-1 receptor (IL-1R), TNF receptor superfamily, and T cell receptor (TCR) signaling. Unlike degradative K48-linked ubiquitination, TRAF6-mediated K63-linked chains serve as scaffolds for signal complex assembly.</p>
<h2 id="core-signaling-pathways">Core Signaling Pathways</h2>
<h3 id="tlril-1r-signaling-pathway">TLR/IL-1R Signaling Pathway</h3>
<p>TRAF6 is recruited to TLR/IL-1R complexes via MyD88 and IRAK proteins. Upon activation, TRAF6 synthesizes K63-linked polyubiquitin chains that recruit TAB2/TAB3-TAK1 complex, leading to activation of NF-�B and MAPK pathways essential for inflammatory responses.</p>
<h3 id="nf-b-activation-pathway">NF-�B Activation Pathway</h3>
<p>TRAF6 activates NF-�B through multiple mechanisms:<br />
- K63-ubiquitination of NEMO/IKK� facilitating IKK complex activation<br />
- Self-ubiquitination creating docking sites for signaling complexes<br />
- Activation of TAK1 which phosphorylates IKK�</p>
<h3 id="ranklrank-signaling">RANKL/RANK Signaling</h3>
<p>In osteoclast differentiation, RANKL binding to RANK recruits TRAF6, which activates NF-�B, MAPK, and NFATc1 pathways essential for osteoclastogenesis and bone remodeling.</p>
<h2 id="pathway-diagram">Pathway Diagram</h2>
<div class="mermaid">
graph TD
    A[TLR/IL-1R] --> B[MyD88: Adaptor]
    B --> C[IRAK1/4: Kinases]
    C --> D[TRAF6: E3 Ligase]

    E[RANKL] --> F[RANK: Receptor]
    F --> D

    G[TCR/CD40] --> D

    D -->|K63-Ub chains| H[TAB2/3: Ub Sensors]
    H --> I[TAK1: Kinase]

    I --> J[IKK Complex]
    J --> K[NF-�B Activation]

    I --> L[MKK3/6]
    L --> M[p38 MAPK]

    I --> N[MKK4/7]
    N --> O[JNK]

    D -->|K63-Ub| P["NEMO/IKKγ"]
    P --> J

    Q[A20: DUB] -.->|removes K63-Ub| D
    R[CYLD: DUB] -.->|negative regulation| D

    K --> S[Inflammatory Genes]
    M --> T[Stress Response]
    O --> U[AP-1 Activation]

    style D fill:#f9f,stroke:#333,stroke-width:2px
    style K fill:#ffd,stroke:#333,stroke-width:1px
</div>

<h2 id="upstream-activators">Upstream Activators</h2>
<ul>
<li><strong>Pattern recognition receptors</strong>: TLRs recognizing PAMPs</li>
<li><strong>Cytokine receptors</strong>: IL-1R, IL-17R, IL-18R</li>
<li><strong>TNF receptor superfamily</strong>: RANK, CD40, BAFFR</li>
<li><strong>Antigen receptors</strong>: TCR, BCR</li>
<li><strong>Growth factor receptors</strong>: TGF-� receptor</li>
</ul>
<h2 id="downstream-effects">Downstream Effects</h2>
<h3 id="nf-b-target-genes">NF-�B Target Genes</h3>
<ul>
<li><strong>Inflammatory cytokines</strong>: IL-6, TNF-�, IL-1�</li>
<li><strong>Chemokines</strong>: IL-8, MCP-1, RANTES</li>
<li><strong>Adhesion molecules</strong>: ICAM-1, VCAM-1, E-selectin</li>
<li><strong>Anti-apoptotic proteins</strong>: BCL-xL, c-IAP1/2</li>
</ul>
<h3 id="mapk-dependent-responses">MAPK-Dependent Responses</h3>
<ul>
<li><strong>AP-1 activation</strong>: via JNK pathway</li>
<li><strong>Inflammatory mediators</strong>: via p38 MAPK</li>
<li><strong>Cell survival and proliferation</strong>: via ERK pathway</li>
</ul>
<h2 id="molecular-mechanisms">Molecular Mechanisms</h2>
<h3 id="e3-ligase-activity">E3 Ligase Activity</h3>
<ul>
<li><strong>RING domain</strong>: Catalyzes ubiquitin transfer</li>
<li><strong>K63-linked chains</strong>: Non-degradative signaling scaffolds</li>
<li><strong>Auto-ubiquitination</strong>: Self-modification for activation</li>
<li><strong>Substrate specificity</strong>: NEMO, TAK1, self</li>
</ul>
<h3 id="protein-interactions">Protein Interactions</h3>
<ul>
<li><strong>TRAF domain</strong>: Receptor binding</li>
<li><strong>Zinc fingers</strong>: Protein-protein interactions</li>
<li><strong>Coiled-coil</strong>: Oligomerization</li>
</ul>
<h2 id="clinical-significance">Clinical Significance</h2>
<h3 id="disease-associations">Disease Associations</h3>
<ul>
<li><strong>Osteopetrosis</strong>: TRAF6 deficiency impairs osteoclastogenesis</li>
<li><strong>Inflammatory diseases</strong>: Dysregulated TRAF6 in arthritis, IBD</li>
<li><strong>Cancer</strong>: Overexpression in various malignancies</li>
<li><strong>Immunodeficiency</strong>: Rare TRAF6 mutations</li>
</ul>
<h3 id="therapeutic-targets">Therapeutic Targets</h3>
<ul>
<li><strong>TRAF6 inhibitors</strong>: Anti-inflammatory therapy</li>
<li><strong>Ubiquitination modulators</strong>: Cancer treatment</li>
<li><strong>Pathway-specific targeting</strong>: Selective immunomodulation</li>
</ul>
<h2 id="regulatory-mechanisms">Regulatory Mechanisms</h2>
<h3 id="negative-regulation">Negative Regulation</h3>
<ul>
<li><strong>A20 (TNFAIP3)</strong>: Deubiquitinase removing K63 chains</li>
<li><strong>CYLD</strong>: DUB specifically cleaving K63-linked chains</li>
<li><strong>USP4</strong>: Deubiquitinates TRAF6</li>
<li><strong>miR-146a</strong>: Post-transcriptional suppression</li>
</ul>
<h3 id="positive-regulation">Positive Regulation</h3>
<ul>
<li><strong>Pellino proteins</strong>: E3 ligases enhancing TRAF6 activity</li>
<li><strong>TRIM proteins</strong>: Facilitate TRAF6 function</li>
<li><strong>Phosphorylation</strong>: Enhances ligase activity</li>
</ul>
<h2 id="tissue-specific-functions">Tissue-Specific Functions</h2>
<ul>
<li><strong>Immune cells</strong>: Inflammatory signaling, T cell activation</li>
<li><strong>Bone</strong>: Osteoclast differentiation and function</li>
<li><strong>Nervous system</strong>: Neuroinflammation, microglial activation</li>
<li><strong>Epithelial cells</strong>: Barrier defense, wound healing</li>
</ul>
<h2 id="cross-pathway-integration">Cross-pathway Integration</h2>
<p>TRAF6 integrates signals from:<br />
1. <strong>Innate immunity</strong>: TLR signaling<br />
2. <strong>Adaptive immunity</strong>: TCR/BCR signaling<br />
3. <strong>Bone metabolism</strong>: RANK/RANKL axis<br />
4. <strong>Cell survival</strong>: PI3K/AKT pathway<br />
5. <strong>Autophagy</strong>: Beclin-1 ubiquitination</p>
    </div>
    <footer style="text-align: center; padding: 20px; color: #666;">
        <small>Generated from TRAF6-pathway.md</small>
    </footer>
</body>
</html>